Foretinib-Based PROTAC 7

Foretinib-Based PROTAC 7 Suppliers list
Company Name: Jilin Province Woda Biotechnology Co., Ltd.  
Tel: 13504435624
Email: 1927928688@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: BOC Sciences  
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Email: 3007606172@qq.com

Foretinib-Based PROTAC 7 manufacturers

  • SJF 8240
  • SJF 8240 pictures
  • $1060.00
  • 2026-07-27
  • CAS:2230821-68-6
  • Purity:
  • Supply Ability: 10g
Foretinib-Based PROTAC 7 Basic information
Product Name:Foretinib-Based PROTAC 7
Synonyms:Foretinib-Based PROTAC 7;1-N'-[3-fluoro-4-[7-[3-[3-[3-[[(2R)-1-[(2R,4S)-4-hydroxy-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-3-oxopropoxy]propoxy]propoxy]-6-methoxyquinolin-4-yl]oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N'1-{3-fluoro-4-[(7-{3-[3-(2-{[(2S)-1-[(2S,4R)-4-hydroxy-2-({[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl}ethoxy)propoxy]propoxy}-6-methoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[(1S)-2-[(5S,3R)-3-Hydroxy-5-[N-[[4-[4-methyl(1,3-thiazol-5-yl)]phenyl]methyl]carbamoyl]pyrrolidinyl]-1-(tert-butyl)-2-oxoethyl]-3-[3-[3-[4-[2-fluoro-4-[[[N-(4-fluorophenyl)carbamoyl]cyclopropyl]carbonylamino]phenoxy]-6-methoxy(7-quinolyloxy)]propoxy]propoxy]propanamide
CAS:2230821-68-6
MF:C58H65F2N7O11S
MW:1106.25
EINECS:
Product Categories:
Mol File:2230821-68-6.mol
Foretinib-Based PROTAC 7 Structure
Foretinib-Based PROTAC 7 Chemical Properties
Boiling point 1226.5±65.0 °C(Predicted)
density 1.341±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO|55.31|50|
pka13.14±0.70(Predicted)
form Solid
color White to light yellow
Safety Information
MSDS Information
Foretinib-Based PROTAC 7 Usage And Synthesis
DescriptionSJF-8240 is a c-MET degrader. It comprises MET inhibitor foretinib joined by a linker to a von Hippel-Lindau (VHL) recruiting ligand. SJF-8240 degrades c-MET within 6 hours in vitro and inhibits agonist-driven AKT phosphorylation and GTL16 cell proliferation. It also degrades exon-14-deleted c-MET in Hs746T cells.
UsesSJF-8240 (PROTAC 7) is a proteolysis targeting chimera (PROTAC) degrader. SJF-8240 induces polyubiquitination of c-Met and inhibits the proliferation of GTL16 cells (IC50=66.7 nM)[1].
storageStore at -20°C
References[1] Burslem GM, et al. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. Cell Chem Biol. 2018 Jan 18;25(1):67-77.e3. DOI:10.1016/j.chembiol.2017.09.009
Foretinib-Based PROTAC 7 Preparation Products And Raw materials
Tag:Foretinib-Based PROTAC 7(2230821-68-6) Related Product Information
Foretinib-Based PROTAC 7 dTAGV-1 FITC-Labeled HGFR Protein, Human (HEK293, His) HGFR Protein, Rat (HEK293, Fc) DT2216 Crizotinib